Get started
Burzynski Research Institute, Inc.Burzynski Research Institute, Inc.Burzynski Research Institute, Inc.

Burzynski Research Institute, Inc.

No trades
See on Supercharts
Overview
Financials
News Ideas Technicals

BZYR fundamentals

Key facts

Market capitalization—
Dividend yield (indicated)—
Price to earnings Ratio (TTM)—
Basic EPS (TTM)—
Founded—
Employees (FY)—
CEO—
Website—
About

Burzynski Research Institute, Inc. engages in the research, production, marketing, promotion, and sale of medical chemical compounds composed of growth-inhibiting peptides, amino acid derivatives, and organic acids under the trade name Antineoplastons. The company was founded by Stanislaw R. Burzynski in 1984 and is headquartered in Houston, TX.

Valuation

Fundamental metrics to determine fair value of the stock

Summary
No data available
There's currently no market capitalization, revenue or net income data to show.
Valuation ratios

Growth and Profitability

Company’s recent performance and margins

Dividends

Dividend yield, history and sustainability

BZYR does not pay dividends
The company has not previously paid dividends and at the moment there is no information about whether it is going to pay them in the future

Financial health

Financial position and solvency of the company